Inspire Investing LLC Sells 12,832 Shares of Maximus, Inc. $MMS

Inspire Investing LLC decreased its holdings in Maximus, Inc. (NYSE:MMS) by 72.3% in the third quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 4,919 shares of the health services provider’s stock after selling 12,832 shares during the period. Inspire Investing LLC’s holdings in Maximus were worth $449,000 as of its most recent SEC filing.

Other large investors also recently added to or reduced their stakes in the company. Parkside Financial Bank & Trust lifted its stake in Maximus by 21.7% in the second quarter. Parkside Financial Bank & Trust now owns 879 shares of the health services provider’s stock worth $62,000 after purchasing an additional 157 shares during the last quarter. GAMMA Investing LLC increased its holdings in shares of Maximus by 13.9% in the third quarter. GAMMA Investing LLC now owns 1,337 shares of the health services provider’s stock worth $122,000 after buying an additional 163 shares during the period. Trust Point Inc. lifted its stake in shares of Maximus by 3.7% in the 3rd quarter. Trust Point Inc. now owns 5,286 shares of the health services provider’s stock valued at $483,000 after acquiring an additional 191 shares during the last quarter. Verus Financial Partners Inc. boosted its holdings in Maximus by 6.7% during the 2nd quarter. Verus Financial Partners Inc. now owns 3,387 shares of the health services provider’s stock valued at $244,000 after acquiring an additional 214 shares during the period. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its position in Maximus by 0.6% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 34,476 shares of the health services provider’s stock worth $2,351,000 after acquiring an additional 221 shares during the last quarter. Hedge funds and other institutional investors own 97.21% of the company’s stock.

Wall Street Analyst Weigh In

A number of brokerages have commented on MMS. Weiss Ratings reaffirmed a “buy (b-)” rating on shares of Maximus in a research note on Monday. Zacks Research downgraded shares of Maximus from a “strong-buy” rating to a “hold” rating in a research note on Monday, October 27th. Two research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $90.00.

Maximus Trading Down 0.2%

NYSE MMS opened at $86.86 on Wednesday. The stock has a market cap of $4.73 billion, a P/E ratio of 15.62 and a beta of 0.56. Maximus, Inc. has a fifty-two week low of $63.77 and a fifty-two week high of $92.50. The stock has a 50 day simple moving average of $84.81 and a two-hundred day simple moving average of $82.16. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.64 and a current ratio of 1.64.

Maximus (NYSE:MMS) last announced its earnings results on Thursday, November 20th. The health services provider reported $1.62 EPS for the quarter, missing analysts’ consensus estimates of $1.63 by ($0.01). Maximus had a net margin of 5.87% and a return on equity of 25.23%. The business had revenue of $1.32 billion for the quarter, compared to the consensus estimate of $1.34 billion. During the same quarter in the prior year, the company earned $1.46 EPS. Maximus’s revenue was up .2% compared to the same quarter last year. Maximus has set its FY 2026 guidance at 7.950-8.250 EPS. On average, analysts forecast that Maximus, Inc. will post 6.15 earnings per share for the current year.

Maximus Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Monday, December 1st. Investors of record on Friday, November 14th were given a dividend of $0.30 per share. The ex-dividend date was Friday, November 14th. This represents a $1.20 annualized dividend and a dividend yield of 1.4%. Maximus’s payout ratio is currently 21.58%.

Insider Transactions at Maximus

In other Maximus news, insider Michelle F. Link sold 4,039 shares of the firm’s stock in a transaction dated Wednesday, December 3rd. The shares were sold at an average price of $86.84, for a total value of $350,746.76. Following the completion of the sale, the insider directly owned 19,542 shares in the company, valued at $1,697,027.28. This trade represents a 17.13% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. 1.60% of the stock is currently owned by insiders.

Maximus Company Profile

Maximus, Inc (NYSE: MMS) is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children’s Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.